5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer

5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer

Introduction To assess the sensitivity fluorescent urine cytology induced by 5-aminolevulinic acid (5-ALA) in the diagnosis of bladder cancer and to compare the sensitivity and specificity with currently available markers approved by the United States Food and Drug Administration (FDA), b...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajendra B Nerli, Shadab Rangrez, Shridhar C. Ghagane, Parth Lalakia, Shoubhik Chandra, Shreya Chandra
Format: Article
Language:English
Published: Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2025-01-01
Series:Brazilian Journal of Oncology
Subjects:
bladder cancer
cytology
urothelial carcinoma
5-aminolevulinic acid
sensitivity
specificity
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791752
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction To assess the sensitivity fluorescent urine cytology induced by 5-aminolevulinic acid (5-ALA) in the diagnosis of bladder cancer and to compare the sensitivity and specificity with currently available markers approved by the United States Food and Drug Administration (FDA), bladder tumour antigen (BTA-TRAK, Bard Diagnostic Sciences, Redmond, WA, United States) assay based on enzyme-linked immunosorbent assay (ELISA), nuclear matrix protein 22 (NMP-22), and conventional cytology.
ISSN:2526-8732

Similar Items